Review





Similar Products

99
Thermo Fisher gene exp spp1 hs00959010 m1
Gene Exp Spp1 Hs00959010 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp spp1 hs00959010 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp spp1 hs00959010 m1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

94
MedChemExpress recombinant opn protein
Recombinant Opn Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant opn protein/product/MedChemExpress
Average 94 stars, based on 1 article reviews
recombinant opn protein - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

96
Proteintech antibody against opn
Antibody Against Opn, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against opn/product/Proteintech
Average 96 stars, based on 1 article reviews
antibody against opn - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

96
Proteintech opn
Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Opn, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opn/product/Proteintech
Average 96 stars, based on 1 article reviews
opn - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

94
MedChemExpress opn group
Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Opn Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opn group/product/MedChemExpress
Average 94 stars, based on 1 article reviews
opn group - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
MedChemExpress mouse ropn protein
Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Mouse Ropn Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ropn protein/product/MedChemExpress
Average 94 stars, based on 1 article reviews
mouse ropn protein - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp spp1 mm00436767 m1
Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Gene Exp Spp1 Mm00436767 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp spp1 mm00436767 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp spp1 mm00436767 m1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and OPN and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated by CGRP and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Journal: Bioactive Materials

Article Title: Composite hydrogel-microsphere delivery system promotes early nerve-mediated bone regeneration and late-stage mechanotransduction-driven bone remodeling via sequential release of NGF and Yoda1

doi: 10.1016/j.bioactmat.2025.10.040

Figure Lengend Snippet: Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and OPN and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated by CGRP and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Article Snippet: Primary antibodies included IL-1β (GB11113, Servicebio, Wuhan, China), CD31 (ab222783, Abcam, UK), EMCN ( GB112648 , Servicebio, Wuhan, China), OPN (22952-1-AP, Proteintech, Wuhan, China), OCN (A6205, ABclonal, Wuhan, China), TUBB3, CGRP, p-YAP1, β-catenin, COL1A, and RUNX2.

Techniques: Co-Culture Assay, Staining, Immunofluorescence, Expressing, Marker, Western Blot, Wound Healing Assay, Migration, Transwell Assay, Tube Formation Assay

Effect of NGF-G/P@Yoda1 on promoting bone regeneration and bone remodeling in femur def ect model. (A–D) Representative immunohistochemical staining images at week 8 for RUNX2 and OPN and semi-quantitative analysis of positive areas to evaluate the osteogenic capacity of composite hydrogels. (E, F) Representative immunofluorescence (IF) staining images at week 8 of OCN and semi-quantitative analysis. (G–J) Representative IF staining images at week 8 of YAP1and β-catenin and semi-quantitative analyses. (K, L) Representative TRAP staining images at week 8 and semi-quantitative analysis of positive areas to assess bone resorption and remodeling. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Journal: Bioactive Materials

Article Title: Composite hydrogel-microsphere delivery system promotes early nerve-mediated bone regeneration and late-stage mechanotransduction-driven bone remodeling via sequential release of NGF and Yoda1

doi: 10.1016/j.bioactmat.2025.10.040

Figure Lengend Snippet: Effect of NGF-G/P@Yoda1 on promoting bone regeneration and bone remodeling in femur def ect model. (A–D) Representative immunohistochemical staining images at week 8 for RUNX2 and OPN and semi-quantitative analysis of positive areas to evaluate the osteogenic capacity of composite hydrogels. (E, F) Representative immunofluorescence (IF) staining images at week 8 of OCN and semi-quantitative analysis. (G–J) Representative IF staining images at week 8 of YAP1and β-catenin and semi-quantitative analyses. (K, L) Representative TRAP staining images at week 8 and semi-quantitative analysis of positive areas to assess bone resorption and remodeling. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Article Snippet: Primary antibodies included IL-1β (GB11113, Servicebio, Wuhan, China), CD31 (ab222783, Abcam, UK), EMCN ( GB112648 , Servicebio, Wuhan, China), OPN (22952-1-AP, Proteintech, Wuhan, China), OCN (A6205, ABclonal, Wuhan, China), TUBB3, CGRP, p-YAP1, β-catenin, COL1A, and RUNX2.

Techniques: Immunohistochemical staining, Staining, Immunofluorescence